triclabendazole

Known as: 6-chloro-5-(2,3-dichlorophenoxy)-2-methylthiobenzimidazole 
 

Topic mentions per year

Topic mentions per year

1983-2017
010203019832017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
A study has been carried out to determine the relative activity of triclabendazole (TCBZ) and its sulphoxide (TCBZSO) and… (More)
Is this relevant?
2007
2007
Triclabendazole is the drug of choice against Fasciola hepatica infections in humans and animals. However, parasite resistance… (More)
Is this relevant?
2004
2004
Benzimidazole anthelmintics are widely used against nematode, cestode and trematode parasites. The drugs undergo several enzyme… (More)
  • figure 1
  • figure 3
  • figure 2
  • table 1
Is this relevant?
2002
2002
Resistance in Fasciola hepatica to triclabendazole ('Fasinex') has emerged in several countries. Benzimidazole resistance in… (More)
Is this relevant?
2002
2002
Human fascioliasis cases in Japan have been reported infrequently and the most appropriate therapy for this disease remains to be… (More)
Is this relevant?
2000
2000
In the winter of 1998/1999, sheep on a farm in the province of North Holland, The Netherlands, died from subacute and chronic… (More)
Is this relevant?
1996
1996
 The effects of the active sulphoxide metabolite of the fasciolicide triclabendazole (Fasinex, Ciba-Geigy) on the vitelline cells… (More)
Is this relevant?
1987
1987
To investigate whether the disposition of triclabendazole (TCBZ) and its metabolites in blood or bile influenced its flukicidal… (More)
Is this relevant?
1986
1986
Triclabendazole was tested in vitro and in vivo against a range of helminths. Although in vitro activity was found against… (More)
Is this relevant?
1983
1983
A new benzimidazole anthelmintic, triclabendazole (CGA-89317) was found to be highly efficient against mature and early immature… (More)
Is this relevant?